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Obj&ves. The aim of this review was to develop a hy@h 
for the molecular pathophysiology of the inherited long 
syndrome. 
Ruckgroun$~ The patbophysiology of the long 
unknown, An abnormality of the sympathetic ne 
been suspected because of the slow heart rates observed and the 
common precipitation of syncope by adrenerfiic stimulation (ex- 
ht). The characteristic QT prolongation and torsade 
tes arrhythmias suggest a potassium ion (KS) abnormality. 
findings from molecular blology and genetic linkage anal- 
dies provide a basis for a new hypothesis that unifies these 
clinical manifestations. 
M&M&. Several recent studies regarding rcas proteins were 
evaluated and correlated. Associations between .ras proteins, G 
protein function and the known features of the long QT syndrome 
The Romano-Ward inherited long QT syndrome is charac- 
terized by autosomal dominant transmission, a prolonged 
QT inlerval on the electrocardiogram (ECG; and ventricular 
tachyarrhythmias c using syncope and sudden death (l-4). 
Several hypotheses have been proposed for the pathophys- 
iology of the syndrome. These include an imbalance of 
cardiac sympathetic system innervation (4-8), a defect in 
potassium ion (K*) membrane conductance (g-12), perhaps 
involving regulatory G proteins (l3), a combination of de- 
nervation and K’ channel abnormalities (13) and a cellular 
defect producing inadequate QT interval shortening in re- 
sponse to increases inheart rate (14). The details of these 
hypotheses, particularly thar of sympathetic mbalance, 
have been discussed in depth by Schwartz and colleagues 
(4,6,7,13) and will not be reiterated here. However, as Zipes 
(15) and Schwartz et al. (13) noted in recent reviews, none of 
the hypotheses fully explain the several unique features of 
the syndrome. 
These characteristic features. which must be encom- 
passed by any hypothesis, include the ECG findings of QT 
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Reudts. The ~oma~o.Ward i 
Harvey ras=l gene on cbromo 
families. Rus genes exhibit G pro 
interfering with signal transduction. 
~oncl~s~o~~~. These various stu 
the disease gene (not necessarily 
function of the gene and interferes WI 
beta-receptor channel signaling. 
plain and unify the several characteristic features o 
syndrome. 
----1 
~roi~n~ati~~, large and sometimes bizarre T waves, the type 
of ventricular rrhythmia (torsade de pointes), the coclmon 
precipitation f syncope and sudden death by events asso- 
ciated with increased sympathetic a tivity (exercise, fright) 
and the slow rest (4,16) and exercise (17) heart rates of 
patients with the long QT syndrome. This report discusses 
several new studies that, taken together, provide greater 
insight into the molecular pathophysiology of the long QT 
syndrome and allow the development of a unifying hypoth- 
esis for the syndrome. 
Pathophysiology f the long QT syndrome. A cornerstone 
observation was made by Keating et al. (18,19), who founo 
the Romano-Ward long QT phenotype to be tightly linked to 
the Harvey ras-I locus on the short arm of chromosome I I,
first in a large multigeneration family (18) and then in six 
additional families with the long QT syndrome (19). PrelIm- 
inary results in I I other families with this syndrome (Towbin 
J, personal communication, August 1991), show linkage at 
the Harvey MS- I locus in 7, and no linkage at this locus in 4. 
These findings uggest genetic heterogeneity in the long QT 
syndrome, which might explain the variable degree of sever- 
ity (frequency of symptoms and sudden deat 
different families with this syndrome. Al~bo~gl~ a 
ras-I gene may not be the specific gene responsible for the 
long QT syndrome, this initial linkage with a rus gene is 
potentially very informative with respect o the molecular 
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as signal t~a~s~~tte~s in 
channels. 
beta-adrenergic re eptor channels. The several recent stud- 
ies that provide support for this hypothesis are described 
below. 
I . A particularly impor- 
tant netic mutation of a ras protein 
significantly impairs the G protein function of the ras pro- 
tein. In an in vitro study, Tsahey et al. (25) showed that 
mutations of human N-ras 1 naarkedlg~ reduced the gua- 
nosine triphosphatase. (GT e, the signal transmitter and 
terminator protein) astivity of the ras ~21 protein. 
mutant variety had only 12% and another only 43% o 
GTPase activity of the normal rus protein. This finding 
suggests mutation of the gene involved in the iong QT 
syndrom d similarly reduce the G tein activity of the 
gene, producing impaired signaling in and beta-receptor 
T ~~~~ornga~jo~ nd torsade 
Yatani et al. (26) demonstrated t lation between ras 
proteins and K+ channels. They showed that recombinant 
ras p21-GTPase activating protein (GAP) inhibits coupling of 
muscarinic (acetylcholine) r ceptors to K+ channels inatria! 
cells, and blocks the K+ current, by preventing coupling of 
the G protein Gk to the receptor. Given this finding, asimilar 
K+ channel impairment in the ventricle might 
for patients with the long QT syndrome, with th 
inhibition blocking the delayed rectifier cu 
prolongation f the action potential, the prolongation a d 
the ventricular arrhythmias. Experimental support for this 
concept is available from animal models of quinidine- or 
cesium chloride-induced inhibition of the K+ delayed recti- 
fier current. These models (27,28) demonstrate action poten- 
d rectifier curren 
scribed, sympathetic stil~~~~t~o~ increases the arn~~~t~dc ot 
early afterdepolarizations and the prevalence ofve~t~~c~lar 
36,37). Similarly, if the 
ired in patients with t 
stimulation might be 
cipitate the ventricul arrhythmias by increasing after- 
depolarizattion ampht to the threshold potential. Further, 
in the animal model, ansae subclaviae stimulation pro- 
er increases in early afterdepolarizatio~ am-
uency of ventricular arrhyth 
ubclaviae stimulation (37). 
differential effect of left versus right ansae sti 
explain the many observations implicating left sympathetic 
stimulation to be more arrhythmogenic than right stimulation 
(4-8). 
The observation that sympathetic stimulation i creases 
arterdepolarization amplitude would also fit with the clinical 
observation that during exercise the terminal portion of the T 
wave frequently becomes quite large, and responsible for QT 
lengthening (17). Also, it has been proposed (38) that after- 
depolarizations may occur with left sympathetic stimulation 
even in normal animals. These findings, therefore, appear to 
be able to account for the relation between the sympathetic 
nervous ystem and the EGG fin and the onset 
syncope and sudden death in pat with the long 
rates, In 1975, Schwartz et al. (4) Erst re- 
ported the observation ofan abnormally slow heart rate in 
patients with the long QT syndrome. This was subsequently 
confirmed by Vincent et al. (16) in very young children at 
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rest and in older patients during exercise (17). These ob- 
servations seemed to fit with the sympathetic imbalance 
hypothesis of deficient right and reflexly overactive l ft 
sympathetic a tivity. However, a recent report (23) sug 
gests that hese heart rate findings may also be explained by 
the abnormal G protein and impaired signal transduction 
hypothesis. As noted, beta-adrenergic e eptors are wei? 
characterized participants in G protein signal transduction 
pathways (23). Heart rate regulation occurs by interactiou 
of sinus node receptors with beta-adrenergic and vagal 
agonists, affecting the pacemaker current Ir in the sinus 
node. Yatani et al. (39) demonstrated hat hese autonomic 
receptors are clir~c~ly co~&I to sinus node pacemaker 1~ 
channels by G proteins, In these in vitro experiments 
the rate of the sinus node cells was controlled by two Ci 
proteins, G, stimulating and G, inhibiting the Ir channels. 
interference of this coupling by the reduced G protein 
activity proposed for the long QT syndrome could, there- 
fore, produce slower than normal heart rates by impaired 
transmission f beta-adrenetpic agonist signals in the sinus 
node cells, 
This mechanism would account for the slower than nor- 
mal heart rate at rest found in young children (4,16), in whom 
sympathetic one contributes to the rate at rest, and the 
normal rate In older subjects (16). in whom parasympathetic 
tone controls the rate at rest. The lower exercise heart rate 
achieved by oldei patients with the long QT syndrome (17) 
would aiso be cor&ient with this mechanism because 
sympathetir tnnp cnntmls heart bite during significant ;xer- 
cise and a defect in the transmission f beta-adrenergic 
agonist signals would result in a slower rate. 
Conclusions. These observations suggest that 8 mutation 
of the gene responsible for the long QT sytrdronle alters the 
6 protein function of the gene and impairs trunsmembrane 
signaling inK” channels and beta-agonist receptor channels. 
This hypothesis appears toexplain the several characteristic 
features of the syndrome and to provide a unified explana- 
tion for the pathophysiology of the syndrome. With identi- 
fication of the specific gene involved and further clarification 
of the molecular physiology, exciting opportunities for pre- 
cise diagnosis and treatment ofthe long QT syndrome art: 
likely to become available. 
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